Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Columbia University Irving Medical Center

Columbia University Irving Medical Center in New York, New York, United States is listed as a site for 510 registered clinical trials, 259 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 510
Ongoing 259

This page covers the site record Columbia University Irving Medical Center in New York, New York, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Columbia University Irving Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 510 trials counted.

  • Phase 1 69 trials
  • Phase 1/2 38 trials
  • Phase 2 86 trials
  • Phase 2/3 7 trials
  • Phase 3 51 trials
  • Phase 4 14 trials
  • Not applicable 145 trials
  • Observational 96 trials
  • Expanded access 3 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 259 trials
  • Completed 178 trials
  • Terminated 63 trials
  • Other 10 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Unknown)

Top of scale: 64

2000: 1 trials (Phase 4 1) 2008: 2 trials (Observational 1, Phase 2 1) 2009: 3 trials (Observational 2, Phase 2 1) 2011: 2 trials (Phase 2 1, Phase 1 1) 2012: 5 trials (Observational 2, Not applicable 1, Phase 3 1, Phase 2 1) 2013: 8 trials (Observational 1, Not applicable 3, Phase 3 1, Phase 1/2 3) 2014: 2 trials (Phase 2 1, Phase 1 1) 2015: 5 trials (Observational 2, Not applicable 2, Phase 3 1) 2016: 15 trials (Observational 3, Not applicable 5, Phase 3 1, Phase 2 3, Phase 1 3) 2017: 24 trials (Other 1, Observational 4, Not applicable 8, Phase 4 2, Phase 2 4, Phase 1/2 3, Phase 1 2) 2018: 27 trials (Observational 8, Not applicable 8, Phase 4 1, Phase 3 2, Phase 2 5, Phase 1/2 2, Phase 1 1) 2019: 37 trials (Observational 5, Not applicable 10, Phase 3 5, Phase 2/3 1, Phase 2 8, Phase 1/2 1, Phase 1 7) 2020: 51 trials (Observational 12, Not applicable 15, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 7, Phase 1/2 2, Phase 1 6) 2021: 64 trials (Observational 20, Not applicable 13, Phase 4 1, Phase 3 5, Phase 2/3 2, Phase 2 15, Phase 1/2 5, Phase 1 3) 2022: 49 trials (Observational 8, Not applicable 14, Phase 4 2, Phase 3 5, Phase 2/3 1, Phase 2 9, Phase 1/2 5, Phase 1 5) 2023: 62 trials (Observational 9, Not applicable 18, Phase 4 2, Phase 3 8, Phase 2 10, Phase 1/2 8, Phase 1 7) 2024: 53 trials (Observational 6, Not applicable 17, Phase 4 3, Phase 3 1, Phase 2/3 1, Phase 2 6, Phase 1/2 7, Phase 1 12) 2025: 47 trials (Observational 4, Not applicable 9, Phase 3 10, Phase 2/3 1, Phase 2 9, Phase 1 14)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 48
2025 47
2024 53
2023 62
2022 49
2021 64
2020 51
2019 37
2018 27
2017 24

2026 is partial: trials registered with a 2026 start date so far, not a full year. 2 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.